Related Experiment Video

Updated: May 23, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

IL-13 receptor-directed cancer vaccines and immunotherapy

Hideyuki Nakashima1, Syed R Husain, Raj K Puri

  • 1Tumor Vaccines & Biotechnology Branch, Division of Cellular & Gene Therapies, Food & Drug Administration, Center for Biologics Evaluation & Research, Bethesda, MD 20892, USA.

Immunotherapy
|April 20, 2012
PubMed

Insights

Interleukin-13 receptor alpha 2 (IL-13Rα2) is a novel tumor antigen. IL-13Rα2-directed cancer vaccines show promise for immunotherapy due to selective tumor expression.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Therapeutic cancer vaccines targeting tumor-associated antigens are under development.
  • Interleukin-13 receptor alpha 2 (IL-13Rα2) is increasingly recognized for its role in cancer.
  • IL-13Rα2 is selectively expressed in various solid tumors, sparing normal tissues.

Purpose of the Study:

  • To summarize the current status of IL-13Rα2-directed cancer vaccines.
  • To explore strategies for enhancing IL-13Rα2-based cancer vaccine efficacy.
  • To discuss the potential of IL-13Rα2 as a target for cancer immunotherapy.

Main Methods:

  • Review of existing research on IL-13Rα2 and cancer vaccines.
  • Analysis of IL-13Rα2 expression patterns in different cancer types.
  • Evaluation of preclinical and clinical data for IL-13Rα2-targeted therapies.

Main Results:

  • IL-13Rα2 is a validated tumor-associated antigen with restricted normal tissue expression.
  • IL-13Rα2-directed vaccines represent a promising immunotherapy strategy.
  • Further research is needed to optimize vaccine design and delivery.

Conclusions:

  • IL-13Rα2 holds significant potential as a target for cancer immunotherapy.
  • Strategies to improve IL-13Rα2-directed vaccines are crucial for clinical success.
  • Optimized IL-13Rα2 vaccines could offer a novel therapeutic option for various solid tumors.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...